Literature DB >> 15581406

Transactivation of cell death signals by glutamate transmission in dopaminergic neurons.

Gabriel A de Erausquin1.   

Abstract

The intrinsic susceptibility of dopaminergic neurons underlies the pathophysiology of Parkinson's disease and is possibly related to developmental injury in schizophrenia. However, the molecular substrates for this susceptibility are not well understood. We review the evidence of selective susceptibility of dopaminergic neurons to excessive glutamate receptor stimulation and discuss the molecular pathways that differentiate between physiological and pathological signaling leading to this particular form of neuronal death. In vitro as well as in vivo, activation of GluRAMPA causes concentration-dependent, severe pruning of neurites and selective death of dopaminergic neurons. In primary cultures of mesencephalon, this form of injury is mediated through release of calcium from intracellular stores (CICR), leading to loss of calcium homeostasis, oxidative stress, and activation of the transcription factor NFkappaB and the cell death protein p53. Post-translational modification of p53 may be an important target for neuroprotection in Parkinson's disease and perhaps in prevention of other neuropsychiatric disorders.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15581406     DOI: 10.1615/critrevneurobiol.v16.i12.120

Source DB:  PubMed          Journal:  Crit Rev Neurobiol        ISSN: 0892-0915


  2 in total

1.  Functional reduction of SK3-mediated currents precedes AMPA-receptor-mediated excitotoxicity in dopaminergic neurons.

Authors:  Bruno A Benítez; Helen M Belálcazar; Agustín Anastasía; Daniel T Mamah; Charles F Zorumski; Daniel H Mascó; Daniel G Herrera; Gabriel A de Erausquin
Journal:  Neuropharmacology       Date:  2010-10-31       Impact factor: 5.250

2.  Dietary Plant Lectins Appear to Be Transported from the Gut to Gain Access to and Alter Dopaminergic Neurons of Caenorhabditis elegans, a Potential Etiology of Parkinson's Disease.

Authors:  Jolene Zheng; Mingming Wang; Wenqian Wei; Jeffrey N Keller; Binita Adhikari; Jason F King; Michael L King; Nan Peng; Roger A Laine
Journal:  Front Nutr       Date:  2016-03-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.